Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Show more
Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma PR Newswire PHILADELPHIA, Nov. 8, 2024 New findings showcase the potential of in vivo...
Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024 PR Newswire PHILADELPHIA, Nov. 5, 2024 Pre-clinical data demonstrate robust...
The INTerpath-009 clinical trial demonstrates continued expansion of the INTerpath clinical program, as the third Phase 3 trial for the investigational individualized neoantigen therapy, V940...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 4.74 | 12.369519833 | 38.32 | 46.3 | 38.2 | 10096061 | 42.51839765 | CS |
| 4 | -11.43 | -20.9763259314 | 54.49 | 56.65 | 35.8 | 10784494 | 43.16859146 | CS |
| 12 | -30.36 | -41.3511304822 | 73.42 | 79.9587 | 35.8 | 7090379 | 53.34723483 | CS |
| 26 | -106.94 | -71.2933333333 | 150 | 158.82 | 35.8 | 5335876 | 75.80746216 | CS |
| 52 | -35.8 | -45.3969059092 | 78.86 | 170.47 | 35.8 | 4904262 | 88.93837338 | CS |
| 156 | -326.74 | -88.3558680368 | 369.8 | 376.4118 | 35.8 | 5229672 | 140.23572154 | CS |
| 260 | 22.46 | 109.029126214 | 20.6 | 497.17 | 17.68 | 9252490 | 146.20627208 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
